Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobulin in Myelodysplastic Syndrome
NCT00466843Phase 2Unknown
- Sponsor
- Office of Rare Diseases Research
- Start
- Apr 2007
- Primary completion
- Feb 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin in myelodysplastic syndrome (MDS), sponsored by Office of Rare Diseases Research. Status: unknown.
02
Drugs
antithymocyte globulin
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00466843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466843.